Class II

Drug Recall: buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceut

Rising Pharma Holding, Inc. · December 29, 2023

Reason for Recall

Presence of Foreign Tablets/Capsules

Product Description

buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

47,976 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0222-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.